pyruvic acid has been researched along with oxidopamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Calvo, S; Fernandez-Gomez, FJ; Galindo, MF; Garcia-Martinez, EM; Gomez-Lazaro, M; Gou-Fabregas, M; Jordán, J; Melero-Fernandez de Mera, R; Pastor, MD; Soler, RM | 1 |
| Cai, AL; Sheline, CT; Shi, C; Zhang, W; Zhu, J | 1 |
| Luo, Y; Sakamoto, K | 1 |
3 other study(ies) available for pyruvic acid and oxidopamine
| Article | Year |
|---|---|
Pyruvate protects cerebellar granular cells from 6-hydroxydopamine-induced cytotoxicity by activating the Akt signaling pathway and increasing glutathione peroxidase expression.
Topics: Animals; Animals, Newborn; Antioxidants; Apoptosis; Cells, Cultured; Cerebellar Cortex; Cytoprotection; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Glutathione Peroxidase; Lipid Peroxidation; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Oxidative Stress; Oxidopamine; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyruvic Acid; Rats; RNA, Messenger; Signal Transduction; Up-Regulation | 2006 |
Mitochondrial inhibitor models of Huntington's disease and Parkinson's disease induce zinc accumulation and are attenuated by inhibition of zinc neurotoxicity in vitro or in vivo.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carrier Proteins; Cation Transport Proteins; Cell Death; Cells, Cultured; Cerebral Cortex; Dihydroxyacetone Phosphate; Disease Models, Animal; Drug Interactions; Embryo, Mammalian; Fructose-Bisphosphatase; Humans; Huntington Disease; Male; Matrix Metalloproteinase 16; Membrane Proteins; Membrane Transport Proteins; Mental Disorders; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Mice, Transgenic; NAD; Neurons; Niacinamide; Nitro Compounds; Oxidopamine; Parkinson Disease; Propionates; Pyruvic Acid; Rats; Rats, Long-Evans; Tyrosine 3-Monooxygenase; Zinc | 2013 |
Ethyl pyruvate protects SHSY5Y cells against 6-hydroxydopamine-induced neurotoxicity by upregulating autophagy.
Topics: Apoptosis; Autophagy; Cell Line, Tumor; Humans; Neuroblastoma; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidopamine; Pyruvic Acid; Reactive Oxygen Species | 2023 |